Pulsed intravenous high-dose dexamethasone in adults with chronic idiopathic thrombocytopenic purpura

R Stasi, M Brunetti, A Pagano, E Stipa, M Masi… - Blood Cells, Molecules …, 2000 - Elsevier
The role of pulsed high-dose dexamethasone (DXM) in the treatment of patients with chronic
idiopathic thrombocytopenic purpura (ITP) is still uncertain. Following an early report in
which it was described as an effective and well-tolerated treatment with a sustained platelet
response in 100% of cases, a number of subsequent studies have failed to confirm such
favorable results. As all these studies were conducted on small numbers of patients, we
investigated further the effectiveness and side effects of this therapeutic modality in a larger …
以上显示的是最相近的搜索结果。 查看全部搜索结果